TrademarkDir
COLLANEX
LIVE

Serial Number

90654047

Owner

Stratus Pharmaceuticals, Inc.

Attorney

Xavier Suarez

First Use Date

Jan 1, 2022

Filing Date

Apr 19, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

COLLANEX Trademark

Serial Number: 90654047 • Registration: 6981434

COLLANEX is a trademark filed by Stratus Pharmaceuticals, Inc. on April 19, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Stratus Pharmaceuticals, Inc. (41 trademarks)

14377 SW 142 Street
Miami, FL 33186

Entity Type: 03

Trademark Details

Filing Date

April 19, 2021

Registration Date

February 14, 2023

First Use Anywhere

January 1, 2022

First Use in Commerce

January 1, 2022

Published for Opposition

January 25, 2022

Goods & Services

Pharmaceutical preparations for skin wounds, namely, wound care powders, gels, and liquids

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 14, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 11, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 10, 2023 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 15, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 15, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 14, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 14, 2022 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Dec 9, 2022 SUPC
USE AMENDMENT FILED
Dec 6, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 6, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 6, 2022 EXRA
SOU EXTENSION 1 GRANTED
Dec 5, 2022 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 5, 2022 AITU
NOTICE OF REVIVAL - E-MAILED
Oct 28, 2022 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Oct 28, 2022 TPEX
PETITION TO REVIVE-GRANTED
Oct 28, 2022 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 28, 2022 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 24, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 24, 2022 ABN6
SOU EXTENSION 1 FILED
Sep 22, 2022 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 22, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 14, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 14, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 14, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 14, 2021 CNEA
ASSIGNED TO EXAMINER
Dec 13, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2021 NWOS

Related Trademarks

More from this Owner

STRATUS PHARMACEUTICALS

STRATUS PHARMACEUTICALS

ACNOCIN

ACNOCIN

ACNOCIN

ACNOCIN

AQUASIL

AQUASIL

AQUASIL

AQUASIL

AZOLEN

AZOLEN